Can you take too much semaglutide — and what happens if you do?

Why the dose schedule exists and what happens when it is exceeded

The titration pathway for Wegovy (starting at 0.25 mg and stepping up gradually over roughly five months) is not a formality. It exists because the body needs time to adjust to the way semaglutide slows gastric emptying and dampens appetite signals. Move through those steps too fast, or accidentally administer an extra injection, and you are essentially hitting your system with more of that effect than it has adapted to.

The most common consequence of too much semaglutide is an intensification of the side effects that are already dose-related at therapeutic levels: nausea, vomiting, diarrhoea, and stomach cramps. These can become severe enough to cause meaningful dehydration, particularly if vomiting is persistent. Dehydration, in turn, can put strain on the kidneys, a risk flagged in the medicine's prescribing information on the eMC.

There is also a hypoglycaemia consideration, mainly relevant for anyone taking semaglutide alongside other glucose-lowering medicines. Semaglutide alone rarely causes low blood sugar in people without diabetes, but in combination with, say, a sulfonylurea or insulin, an accidental extra dose could tip blood glucose into a problematic range. If you are on other medicines as well, that context matters and should be discussed with your prescriber.

Our semaglutide overview covers the standard prescribing framework in more detail if you want the broader picture.

The specific risks that warrant urgent help, not a wait-and-see approach

Most dose errors produce unpleasant but self-limiting symptoms. Severe overdose is a different situation. The signals that mean you should act rather than manage at home include severe stomach pain (especially pain that spreads towards the back) persistent vomiting that means you cannot keep fluids down, signs of dehydration (dark urine, dizziness on standing, confusion), or symptoms of a serious allergic reaction such as swelling of the face or throat.

The pancreatitis risk is worth taking seriously. In January 2026 the MHRA issued a Drug Safety Update on GLP-1 receptor agonist medicines specifically to remind patients and clinicians that acute pancreatitis, though uncommon, can be serious; the hallmark symptom is severe, persistent abdominal pain that may radiate to the back. An accidental double dose does not automatically cause pancreatitis, but it is not a risk to sit on.

If you are unsure how much you have taken (for instance if you injected a pen without being sure whether you had already used it that week) the guidance on what to do after a possible semaglutide overdose sets out the practical steps clearly. The short answer: contact a healthcare professional that day rather than waiting for symptoms to develop or worsen.

How dose errors happen and how to reduce the risk

The most common real-world cause of accidental extra dosing is a simple memory lapse. Semaglutide is a once-weekly injection, and seven days can blur together. Keeping the pen somewhere visible and consistent (some people tuck it in the fridge door next to items they reach for daily) makes it harder to forget whether a weekly dose has gone in or not. A note in a phone calendar, a weekly pill tracker, or even a sticky note on the pen box are all practical fixes.

A second, less obvious source of errors is switching between brands or formulations without clinical oversight. Someone moving from Ozempic (the diabetes-licensed semaglutide) to Wegovy, or now from the injection to the new oral Wegovy tablet, carries a different dose and a different schedule. These are not straightforward substitutions. The question of who semaglutide is suitable for and in what form is genuinely a clinical one, not a product-choice the patient should navigate alone.

It is also worth being clear about what cannot be safely adjusted at home: if a dose has felt too low and you are tempted to take more pens per week to accelerate progress, that falls outside the licensed schedule and creates real risk. Dose changes for Wegovy are made by your prescriber, based on tolerability and response, not by self-titrating. If you feel your current dose is not working, that is a conversation to have with your clinical team, not a problem to solve by adjusting the frequency yourself. You can read about the specific risks associated with taking too much Wegovy for more detail on that scenario.

When to call for help, and what the right next step looks like

If symptoms after a suspected overdose are mild (a bit more nausea than usual, perhaps some loose stools) and you are otherwise well, monitoring closely and staying hydrated is reasonable. Let your prescriber know what happened at your next check-in.

If symptoms are moderate or severe, or you are simply unsure, NHS 111 is the right first call. They can advise based on your specific symptoms and, if needed, direct you to A&E. Do not take another dose until you have spoken to a clinician. Reporting a suspected adverse reaction through the MHRA Yellow Card scheme is something any patient can do and helps build the evidence base on real-world safety.

For context on the cost and structure of privately prescribed semaglutide, our Wegovy cost page covers what a legitimate private prescription typically involves in the UK. And if you have questions about your treatment or are thinking about starting, a free consultation with our prescribers is the place to start, a real clinician reviews every submission, and that review happens the same day.